Biopharma News

Feb 28, 2018
By BioPharm International Editors
A jury verdict requiring Gilead Sciences to pay $2.54 billion for patent infringement to competitor Merck & Co. over Gilead's Harvoni (ledipasvir and sofosbuvir) and Sovaldi (sofosbuvir), two best-selling hepatitis C drugs, has been overturned.
Feb 28, 2018
By BioPharm International Editors
Merck & Co. has acquired oncology-focused biopharmaceutical company Viralytics to strengthen Merck's oncology pipeline.
Feb 27, 2018
By BioPharm International Editors
Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.
Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 15, 2018
By BioPharm International Editors
Fluarix Tetra has been approved for use in children aged six months and above.
Feb 14, 2018
By BioPharm International Editors
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
Feb 14, 2018
By BioPharm International Editors
The companies will work together on developing regenerative medicine therapies for heart failure.
Feb 09, 2018
By BioPharm International Editors
The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories.
Feb 07, 2018
By BioPharm International Editors
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
Feb 06, 2018
By BioPharm International Editors
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
native1_300x100
lorem ipsum